Cerebrospinal fluid biomarkers for Parkinson disease diagnosis and progression

DJ-1 and α-synuclein in human cerebrospinal fluid as biomarkers of Parkinson’s disease

(2010) Zhen Hong et al.   BRAIN

Differential diagnosis of parkinsonism: a metabolic imaging study using pattern analysis

(2010) Chris C Tang et al.   LANCET NEUROLOGY

CSF Aβ42and tau in Parkinson's disease with cognitive impairment

(2010) Thomas J. Montine et al.   MOVEMENT DISORDERS

Microglial Cx3cr1 knockout prevents neuron loss in a mouse model of Alzheimer's disease

(2010) Martin Fuhrmann et al.   NATURE NEUROSCIENCE

Biomarkers in Huntington's and Parkinson's Disease

(2009) Gráinne C. O’Keeffe et al.   Annals of the New York Academy of Sciences

Microglial Activation in Alzheimers Disease

(2009) Johannes Schlachetzki et al.   Current Alzheimer Research

Cerebrospinal tau, phospho-tau, and beta-amyloid and neuropsychological functions in Parkinson's disease

(2009) Yaroslau Compta et al.   MOVEMENT DISORDERS

Biological fluid biomarkers in neurodegenerative parkinsonism

(2009) Michael Eller et al.   Nature Reviews Neurology

High-resolution diffusion tensor imaging in the substantia nigra of de novo Parkinson disease

(2009) D. E. Vaillancourt et al.   NEUROLOGY

CSF Multianalyte Profile Distinguishes Alzheimer and Parkinson Diseases

(2008) Jing Zhang et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Neural progenitors, neurons and oligodendrocytes from human umbilical cord blood cells in a serum-free, feeder-free cell culture

(2008) Shawn J. Chua et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Cerebrospinal Fluid Biomarkers in Parkinson's Disease with Dementia and Dementia with Lewy Bodies

(2008) Lucilla Parnetti et al.   BIOLOGICAL PSYCHIATRY

Chemokines and common variable immunodeficiency; possible contribution of the fractalkine system (CX3CL1/CX3CR1) to chronic inflammation

(2008) Børre Fevang et al.   CLINICAL IMMUNOLOGY

Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

(2008) Brit Mollenhauer et al.   EXPERIMENTAL NEUROLOGY

Role of CX3CR1 (Fractalkine Receptor) in Brain Damage and Inflammation Induced by Focal Cerebral Ischemia in Mouse

(2008) Ádám Dénes et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Changes in the levels of plasma soluble fractalkine in patients with mild cognitive impairment and Alzheimer's disease

(2008) Tae-Suk Kim et al.   NEUROSCIENCE LETTERS

Cerebrospinal fluid α-synuclein in neurodegenerative disorders—A marker of synapse loss?

(2008) Annika Öhrfelt et al.   NEUROSCIENCE LETTERS

Fractalkine and TGF-β1 levels reflect the severity of chronic pancreatitis in humans

(2008) Mikihiko Yasuda et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Core candidate neurochemical and imaging biomarkers of Alzheimer’s disease

(2007) Harald Hampel et al.   Alzheimers & Dementia

Association of olfactory dysfunction with risk for future Parkinson's disease

(2007) G. Webster Ross et al.   ANNALS OF NEUROLOGY